COMMUNIQUÉS West-GlobeNewswire

TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer
04/09/2018
All evaluable patients experienced tumor shrinkage Protocol defined response criteria achieved and trial expansion ongoing WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology- [...]
Retrophin Announces Proposed Convertible Senior Notes Offering
04/09/2018
SAN DIEGO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced its intention to offer, subject to market and other conditions, $200 million aggregate principal amount of convertible senior [...]
Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia
04/09/2018
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced the publication of a peer reviewed paper in Leukemia authored by scientists from the Dana Farber Cancer Institute [...]
Rubius Therapeutics to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
04/09/2018
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, announced today that [...]
Dova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP
04/09/2018
DURHAM, N.C., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a specialty pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where [...]
Helius Medical Technologies to Participate in the 20th Annual Global Investment Conference Sponsored by Rodman & Renshaw and H.C. Wainwright & Co.
04/09/2018
NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced it will be [...]
Sol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne Vulgaris
04/09/2018
Announces Positive End-of-Phase II Meeting with the FDA Receives Special Protocol Assessment (SPA) Agreement from FDA Company expects to commence the TWIN Phase III clinical trials in the fourth quarter of 2018 with top [...]
Dr. Yaron Werber, Chief Business and Financial Officer, to Return to Wall Street
04/09/2018
Dr. Werber will join Cowen and Company as Managing Director and Senior Biotechnology Analyst effective September 24, 2018 Ovid has initiated a search to select a new CFO NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ovid [...]
HealthEquity Reports Second Quarter Ended July 31, 2018 Financial Results
04/09/2018
Highlights of the second quarter include: Revenue of $71.1 million, an increase of 25% compared to Q2 FY18. Net income of $22.5 million, an increase of 33% compared to Q2 FY18. Net income per diluted share of $0.36 [...]
Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology
04/09/2018
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that preclinical data for its first-in-class anti-APRIL antibody BION-1301 was presented at the 5 th European [...]
BOAZ is handcrafting cannabis in Calgary
04/09/2018
Calgary media are invited to private tours of a new state-of-the-art cannabis production facility. CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The grow lamps are on and cultivation begins in Calgary’s latest [...]
Project HOPE Celebrates 60 Years with Launch of New Brand Identity
04/09/2018
Millwood, VA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Project HOPE today announced the launch of a new brand identity, logo, and website highlighting the global health and humanitarian relief organization’s unique mission [...]
Morningside Retirement Community Named Great Place to Work
04/09/2018
FULLERTON, CALIF., Sept. 04, 2018 (GLOBE NEWSWIRE) -- The Morningside continuing care retirement community in Fullerton, California, has been certified as a top workplace by the independent research and consulting firm [...]
Publication of eQUEST Study Results Demonstrate that eSight 3 is a Clinically Effective Device for the Visually Impaired
04/09/2018
Significant results to be published in September 2018 issue of Optometry and Vision Science TORONTO and LOS ANGELES, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Dr. Brian Mech, President and CEO of eSight, is proud to announce [...]
NANOBIOTIX half year results for the six months ended June 30, 2018
04/09/2018
Nanobiotix half year results for the six months ended June 30, 2018 Major milestones achieved with the success of Soft Tissue Sarcoma phase III clinical trial with first-in-class NBTXR3 product Overall expenses [...]
NANOBIOTIX : Résultats semestriels au 30 juin 2018
04/09/2018
Résultats semestriels au 30 juin 2018 Etapes majeures réalisées grâce au succès de l'essai clinique de phase III avec le produit premier de sa classe NBTXR3 Dépenses conformes aux prévisions de la Société Evènements [...]
Sanofi reaches civil settlement with US SEC
04/09/2018
Paris - September 4, 2018 - Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the U.S. Foreign Corrupt [...]
Sanofi conclut un accord avec la « Securities and Exchange Commission » américaine
04/09/2018
Sanofi conclut un accord avec la « Securities and Exchange Commission » américaine Paris - Le 4 septembre 2018 - Sanofi a conclu un accord avec l'Autorité des marchés financiers des États-Unis (US Securities and [...]
CORRECTION -- BioCryst Reports Positive Results Across Multiple Endpoints in ZENITH-1 Trial of Oral BCX7353 as Acute Therapy for Hereditary Angioedema (HAE) Attacks
04/09/2018
—Safety and efficacy data support advancement of 750 mg dose as first oral therapy for acute HAE attacks— In a release issued under the same headline earlier today by BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), please [...]

Pages